Dr. Cande Rogert discusses emerging trends in sequencing and how new genomic technologies are shaping multiomics and clinical ...
Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...
Illumina and the Center for Data-Driven Discovery in Biomedicine launched a large pediatric genomic data initiative focused on rare diseases and cancer. The collaboration will analyze 100,000 whole ...
Illumina and D3b bring genomic data and scalable software to the fight against paediatric cancer and rare disease: San Diego Thursday, April 16, 2026, 11:00 Hrs [IST] Illumina, an ...
What if the biggest winners in biotech weren’t the ones promising miracle cures, but the ones quietly supplying the picks and ...
Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...
Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March ...
Human papillomavirus (HPV) is a double-stranded circular DNA virus with a genome of approximately 7–8 kb. This study aimed to ...
Human papillomavirus (HPV) is a double-stranded circular DNA virus with a genome of approximately 7–8 kb. This study aimed to establish an overlapping extension polymerase chain reaction method for ...
A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, has ...
Illumina ( (ILMN) ) just unveiled an announcement.
Stanford develops protein-to-DNA method enabling high-throughput protein sequencing Technique detects up to 1,000 times more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results